METTL3 and neoplasm: This is the first report that m6A regulator can promote tumor resistance to radiotherapy by suppressing radiation-induced ferroptosis (Fig. 4), suggesting that m6A regulator may serve as a potential therapeutic target and prognostic biomarker.